Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of Disulfiram and Copper for Patients with Metastatic Breast Cancer
Not recruiting
Investigated Drugs:
Study Comparing Chemotherapy and Abemaciclib with Hormone Therapy for Patients with ER+ HER2- Metastatic Breast Cancer with Visceral Involvement
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study on Trastuzumab Emtansine, Pertuzumab, and Atezolizumab for Patients with HER2-Positive Metastatic Cancer Who Benefited from Previous Treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+5
Study of [177Lu]Lu-NeoB and Capecitabine for Patients with Advanced Breast Cancer Resistant to Hormone Therapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
Not recruiting
Investigated Drugs:
+6